what this node claims
Initial digest — MCHR1
AlphaFold v6 prediction landed for **MCHR1** (Melanin-concentrating hormone receptor 1). UniProt accession: `Q99705`. Lane: `sleep_circadian`. Mean per-residue pLDDT: **84.43**. _(no notes)_
vertical proof spine
evidence / risk instrument
39%
low debt pressure
29%
28%structuredebt
pLDDT pending
55%evidencethin
grade C
0%gatesdebt
0/5 gates
100%riskstrong
0 hard flags
22%exportdebt
no export
33%lineagedebt
incomplete spine
proof completeness
33% missing target, alphafold_metric, candidate, export- 01 target
- 02 fold
- 03 alphafold metric
- 04 candidate
- 05 finding
- 06 export
Metrics and receipt inputs
- confidence
- 0.6
- evidence refs
- 1
AlphaFold metrics visual
Confident backbone model
353 residues / min 21.73 / max 98.56 / source alphafold db
Very high
63.5%
224 residues / >=90
Confident
20.4%
72 residues / 70-89
Low
6.8%
24 residues / 50-69
Very low
9.3%
33 residues / <50
usable fold context with explicit model-confidence limits
Near-complete coverage / observed 353 of 353 residues.
- residues 1-39 / mean 35.94
- residues 327-336 / mean 57.7
- residues 69-74 / mean 55.9
- residues 352-353 / mean 59.09
proof debt register
29%
Visible limits, not hidden cleanup.
Peptide RX keeps unresolved proof debt attached to the public receipt. Some debts should be resolved; redaction and research-use boundaries should stay visible.